Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitors
US9382257B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2015 |
| Grant date | Jul 5, 2016 |
| Priority date | — |
| Expiry date | Apr 16, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having the formula I wherein R1 and R2 are as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.